title: Would apixaban be a good option for extended anticoagulation in venous thromboembolism?
authors.affiliation: Department of Biomedical and Clinical Sciences, Internal Medicine III, L. Sacco Hospital, University of Milan, via GB Grassi, 74, 20157, Milan, Italy, folletta@tin.it.
authors.forename: Maddalena Alessandra
authors.initials: MA
authors.lastname: Wu
authors.forename: Giulia
authors.initials: G
authors.lastname: Cernuschi
mesh_terms: D065427:Factor Xa Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D057194:Intention to Treat Analysis; D011720:Pyrazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D011728:Pyridones / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D054556:Venous Thromboembolism / Q000188:drug therapy*
chemical_list: D065427:Factor Xa Inhibitors; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban